Immunocore Holdings plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US45258D1054

SecurityIMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership230,399 shares
Latest Disclosed Value $ 6,946,530
Citadel Advisors Llc ownership in IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 230,399 shares of Immunocore Holdings plc - Depositary Receipt (Common Stock) (US:IMCR) valued at $6,946,530 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 234,268 shares of Immunocore Holdings plc - Depositary Receipt (Common Stock). This represents a change in shares of -1.65% during the quarter. The current value of the position is $6,517,988 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (IMCR) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 9,900 of underlying shares valued at $298,485 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 230,399 -3,869 -1.65 6,947 -14.57 0.0010
2026-02-17 2025-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 234,268 192,070 455.16 8,131 430.40 0.0012
2025-11-14 2025-09-30 13F IMMUNOCORE HLDGS ADS 45258D105 42,198 -162,019 -79.34 1,533 -76.08 0.0002
2025-08-14 2025-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 204,217 150,581 280.75 6,408 302.77 0.0011
2025-05-15 2025-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 53,636 -22,034 -29.12 1,591 -28.72 0.0003
2025-02-14 2024-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 75,670 16,562 28.02 2,232 21.30 0.0004
2024-11-14 2024-09-30 13F IMMUNOCORE HLDGS ADS 45258D105 59,108 -169,844 -74.18 1,840 -76.29 0.0004
2024-08-14 2024-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 228,952 166,927 269.13 7,759 92.48 0.0016
2024-05-15 2024-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 62,025 -178,331 -74.19 4,032 -75.45 0.0008
2024-02-14 2023-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 240,356 68,784 40.09 16,421 84.42 0.0033
2023-11-14 2023-09-30 13F IMMUNOCORE HLDGS ADS 45258D105 171,572 135,695 378.22 8,905 313.95 0.0019
2023-08-14 2023-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 35,877 -24,445 -40.52 2,151 -27.87 0.0004
2023-05-15 2023-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 60,322 -139,266 -69.78 2,982 -73.82 0.0007
2023-02-14 2022-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 199,588 -94,814 -32.21 11,390 -17.58 0.0027
2022-11-14 2022-09-30 13F IMMUNOCORE HLDGS ADS 45258D105 294,402 209,902 248.40 13,820 338.31 0.0031
2022-08-15 2022-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 84,500 24,774 41.48 3,153 76.54 0.0008
2022-05-16 2022-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 59,726 47,603 392.67 1,786 330.36 0.0004
2022-02-14 2021-12-31 13F IMMUNOCORE HLDGS ADS 45258D105 12,123 -10,405 -46.19 415 -50.30 0.0001
2021-11-15 2021-09-30 13F IMMUNOCORE HLDGS Depository Receipt 45258D105 22,528 -28,782 -56.09 835 -58.33 0.0002
2021-08-16 2021-06-30 13F IMMUNOCORE HLDGS ADS 45258D105 51,310 -126 -0.24 2,004 -8.45 0.0004
2021-05-21 2021-03-31 13F/A-1 IMMUNOCORE HLDGS ADS 45258D105 51,436 51,436 2,189 0.0005
2021-05-17 2021-03-31 13F IMMUNOCORE HLDGS ADS 45258D105 51,436 51,436 2,189 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F IMMUNOCORE HLDGS ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNOCORE HLDGS ADS Call 8,800 320 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNOCORE HLDGS ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNOCORE HLDGS ADS Call 12,700 -9.29 377 -8.96 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNOCORE HLDGS ADS Call 14,000 -48.72 413 -51.35 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNOCORE HLDGS ADS Call 27,300 -17.02 850 -23.79 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNOCORE HLDGS ADS Call 32,900 -33.54 1,115 -65.37 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNOCORE HLDGS ADS Call 49,500 175.00 3,218 161.76 n/a n/a n/a
2024-02-14 2023-12-31 13F IMMUNOCORE HLDGS ADS Call 18,000 -36.40 1,230 -16.28 n/a n/a n/a
2023-11-14 2023-09-30 13F IMMUNOCORE HLDGS ADS Call 28,300 88.67 1,469 63.29 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNOCORE HLDGS ADS Call 15,000 -12.79 899 5.76 n/a n/a n/a
2023-05-15 2023-03-31 13F IMMUNOCORE HLDGS ADS Call 17,200 53.57 850 33.02 n/a n/a n/a
2023-02-14 2022-12-31 13F IMMUNOCORE HLDGS ADS Call 11,200 124.00 639 171.91 n/a n/a n/a
2022-11-14 2022-09-30 13F IMMUNOCORE HLDGS ADS Call 5,000 -31.51 235 -13.60 n/a n/a n/a
2022-08-15 2022-06-30 13F IMMUNOCORE HLDGS ADS Call 7,300 272 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMMUNOCORE HLDGS ADS Put 9,900 25.32 298 8.76 n/a n/a n/a
2026-02-17 2025-12-31 13F IMMUNOCORE HLDGS ADS Put 7,900 19.70 274 14.64 n/a n/a n/a
2025-11-14 2025-09-30 13F IMMUNOCORE HLDGS ADS Put 6,600 -80.30 240 -77.26 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNOCORE HLDGS ADS Put 33,500 335.06 1,051 360.96 n/a n/a n/a
2025-05-15 2025-03-31 13F IMMUNOCORE HLDGS ADS Put 7,700 -20.62 228 -20.28 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNOCORE HLDGS ADS Put 9,700 -48.13 286 -50.86 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNOCORE HLDGS ADS Put 18,700 3.31 582 -5.06 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNOCORE HLDGS ADS Put 18,100 162.32 613 36.83 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNOCORE HLDGS ADS Put 6,900 -32.35 448 -35.63 n/a n/a n/a
2024-02-14 2023-12-31 13F IMMUNOCORE HLDGS ADS Put 10,200 920.00 697 1,264.71 n/a n/a n/a
2023-11-14 2023-09-30 13F IMMUNOCORE HLDGS ADS Put 1,000 52 n/a n/a n/a
2023-08-14 2023-06-30 13F IMMUNOCORE HLDGS ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F IMMUNOCORE HLDGS ADS Put 1,000 -83.61 49 -85.92 n/a n/a n/a
2023-02-14 2022-12-31 13F IMMUNOCORE HLDGS ADS Put 6,100 -60.39 348 -51.87 n/a n/a n/a
2022-11-14 2022-09-30 13F IMMUNOCORE HLDGS ADS Put 15,400 0.65 723 26.62 n/a n/a n/a
2022-08-15 2022-06-30 13F IMMUNOCORE HLDGS ADS Put 15,300 571 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.